AstraZeneca
The Portfolio Analytics Lead at Alexion, AstraZeneca Rare Disease will conduct portfolio forecasting and reporting to define financial opportunities across indications, supporting enterprise-wide decision making. The role partners with senior leaders across global and regional functions to develop strategic business cases, scenario models, and long‑term revenue forecasts.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
4% below the average for this role
CD&A - Senior Director, US Forecasting, Rare Disease
Amgen
Director, Global Patient Advocacy Lead
American Association of Physicists in Medicine
Sr. Director, Portfolio Strategy and Analytics | Onsite San Diego HQ
lifelancer
Sr. Director, Portfolio Strategy and Analytics | Onsite San Diego HQ
Neurocrine Biosciences
Portfolio Analytics Manager
mjkconnections
Executive Director, Oncology Business Unit, Strategy
lifelancer